Ovid Therapeutics Statistics
Total Valuation
OVID has a market cap or net worth of $303.31 million. The enterprise value is $226.28 million.
Important Dates
The last earnings date was Wednesday, March 18, 2026, before market open.
| Earnings Date | Mar 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OVID has 131.87 million shares outstanding. The number of shares has increased by 3.99% in one year.
| Current Share Class | 131.87M |
| Shares Outstanding | 131.87M |
| Shares Change (YoY) | +3.99% |
| Shares Change (QoQ) | +14.85% |
| Owned by Insiders (%) | 3.04% |
| Owned by Institutions (%) | 33.62% |
| Float | 101.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 41.82 |
| Forward PS | 936.58 |
| PB Ratio | 2.29 |
| P/TBV Ratio | 2.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 31.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.97, with a Debt / Equity ratio of 0.10.
| Current Ratio | 8.97 |
| Quick Ratio | 8.40 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -17.51% and return on invested capital (ROIC) is -79.10%.
| Return on Equity (ROE) | -17.51% |
| Return on Assets (ROA) | -21.82% |
| Return on Invested Capital (ROIC) | -79.10% |
| Return on Capital Employed (ROCE) | -29.75% |
| Weighted Average Cost of Capital (WACC) | 4.90% |
| Revenue Per Employee | $315,304 |
| Profits Per Employee | -$745,304 |
| Employee Count | 23 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +465.11% in the last 52 weeks. The beta is 0.16, so OVID's price volatility has been lower than the market average.
| Beta (5Y) | 0.16 |
| 52-Week Price Change | +465.11% |
| 50-Day Moving Average | 1.79 |
| 200-Day Moving Average | 1.31 |
| Relative Strength Index (RSI) | 59.83 |
| Average Volume (20 Days) | 4,814,817 |
Short Selling Information
The latest short interest is 5.45 million, so 4.14% of the outstanding shares have been sold short.
| Short Interest | 5.45M |
| Short Previous Month | 5.09M |
| Short % of Shares Out | 4.14% |
| Short % of Float | 5.39% |
| Short Ratio (days to cover) | 3.18 |
Income Statement
In the last 12 months, OVID had revenue of $7.25 million and -$17.14 million in losses. Loss per share was -$0.23.
| Revenue | 7.25M |
| Gross Profit | 7.25M |
| Operating Income | -42.44M |
| Pretax Income | -17.41M |
| Net Income | -17.14M |
| EBITDA | -42.17M |
| EBIT | -42.44M |
| Loss Per Share | -$0.23 |
Full Income StatementBalance Sheet
The company has $69.64 million in cash and $13.42 million in debt, with a net cash position of $77.03 million or $0.58 per share.
| Cash & Cash Equivalents | 69.64M |
| Total Debt | 13.42M |
| Net Cash | 77.03M |
| Net Cash Per Share | $0.58 |
| Equity (Book Value) | 130.66M |
| Book Value Per Share | 1.00 |
| Working Capital | 66.08M |
Full Balance SheetCash Flow
| Operating Cash Flow | -38.33M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 273,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -38.33M |
| FCF Per Share | -$0.29 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -585.20% and -240.13%.
| Gross Margin | 100.00% |
| Operating Margin | -585.20% |
| Pretax Margin | -240.13% |
| Profit Margin | -240.13% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OVID does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.99% |
| Shareholder Yield | -3.99% |
| Earnings Yield | -5.65% |
| FCF Yield | -12.64% |
Analyst Forecast
The average price target for OVID is $4.20, which is 82.61% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.20 |
| Price Target Difference | 82.61% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 53.86% |
| EPS Growth Forecast (5Y) | 16.30% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OVID has an Altman Z-Score of -1.44 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.44 |
| Piotroski F-Score | 2 |
